Anlotinib plus penpulimab has demonstrated encouraging activity and safety in a phase 2 study. In this phase 3 trial, we aimed to assess whether the combination of anlotinib plus penpulimab improved ...

Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial ...

Instil Bio plans to start a phase 1 trial of AXN-2510 for solid tumors following FDA IND clearance.

Lineage Cell Therapeutics recently announced 36-month results from a phase 1/2a clinical study (NCT02286089) of RG6501 (OpRegen) for the treatment of geographic atrophy (GA), secondary to age-related ...

Phase 1 of the voting for the 2025 PRO SPIRIT MLB All-Star Ballot concluded at noon ET. Now the wait is on to find out which players will move on to Phase 2 in their quest to reach the 2025 All-Star ...

Lilly’s oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The New England Journal of ...